NATREL Promotes IV Sedative-Hypnotic Agent

Parsippany, NJ, December 1, 2010 — NATREL Communications has been working as Agency of Record for LUSEDRA^® (fospropofol disodium) Injection CIV from Eisai Inc.

NATREL Communications is a health care advertising agency that serves pharmaceutical companies and brands through integration of traditional and innovative strategies, tactics, and media. The firm’s comprehensive service spectrum ranges from positioning strategy and all aspects of branding (including global brand development) to tactical implementation (including world-class creative execution). The company relies on a wide-open creative brainstorming process and offers a proprietary Brand Personality Workshop that is unique in the industry.

Eisai Inc., a US pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., is headquartered in Woodcliff Lake, New Jersey.

For more information, contact Allan Trent at NATREL Communications, 119 Cherry Hill Road, Parsippany, NJ 07054; (tel) 973.292.8400; (fax) 973.292.9101; or access the NATREL Web site at www.natrelusa.com.